OrbiMed Global Healthcare GP LLC

CIK 1673892 · last filed 2020-01-31

OrbiMed Global Healthcare GP LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for SRRA, was dated Jan 31, 2020. Across all open-market trades the lifetime net is +$18.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $28.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$28.90M

Companies

2

Total Filings

2

Lifetime Open-Market Net

$18.00M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Sierra Oncology, Inc. (SRRA) Delisted	Director	1,477,320	$54.99	$81.24M	$0	1	2020-01-31
NTLA	Director	2,603,646	$11.10	$28.90M	$18.00M	1	2016-05-13

Recent Filings

2 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2020-01-31	Sierra Oncology, Inc. (SRRA) Delisted	Conv (C)	+5,909,280	$0	EDGAR
2016-05-13	NTLA	Mixed	+10,648,720	$18.00M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.